首页 > 市场调查报告书 > 製药

药物开发人工智能人工智能药物研发

市场调查报告书

商品编码

1529872

药物发现中人工智慧的市场规模、份额和趋势分析报告：按治疗领域、按应用、按地区和细分市场预测，2024-2030

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Space (Oncology, Neurodegenerative Diseases), By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年07月26日 | 出版商:

Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

药物发现领域人工智慧市场的成长与趋势：

预计到 2030 年，人工智慧在药物发现领域的全球市场规模将达到 91 亿美元，预计 2024 年至 2030 年复合年增长率将达到 29.7%。

预计2023年至2030年复合年增长率为29.6%。这场大流行导致人工智慧在製药业的广泛采用。人工智慧及其相关平台旨在增强医学影像和诊断、慢性病管理和药物设计。与扫描相同资料的人工智慧系统相比，它需要更多的人力时间，从而降低了整体成本并使其成为更可行的方法。

药物优化和再利用应用领域在 2022 年占据了最大的收益占有率。人工智慧平台可以帮助识别药物标靶蛋白，以确定潜在的药物不利事件和副作用。药物分子可以重复使用，以提高疗效并最大限度地减少副作用。使用人工智慧平台可以更快地修改和研究公司的药物组合，以加速开发新药。

2022年，肿瘤学领域占据最大的收益占有率。大多数製药公司正在与人工智慧新兴企业合作优化癌症研究，但这仍然是一个未知领域，还有很多东西要发现。即使对于训练有素的放射科医生来说，人工智慧系统也能比常规扫描更早识别出癌症。其结果是寿命更长，还可以识别用于癌症研究和药物开发的标记物。患者会接受适合其基因组成的治疗。

2022年的市场由北美主导。目前，许多高科技公司正在投入资金和精力，在製药公司中利用人工智慧。 IBM、微软和其他科技巨头等公司正在与研究机构建立合作关係，以加速多种适应症的药物开发和临床试验。新兴国家也在寻找经济有效的方法来部署人工智慧技术来进行药物开发和疾病理解。

药物发现市场中的人工智慧报告亮点

药物优化和再利用的应用领域占据市场主导地位，2022年收益占有率超过53.9%。
按治疗领域划分，肿瘤学占最大收益占有率，2022 年将超过 23.4%。预计感染疾病产业在预测期内将出现最快的成长速度。
预计 2023 年至 2030 年，亚太地区将以最快的复合年增长率扩张。同时，该地区的新兴国家越来越多地采用人工智慧作为了解疾病和支持药物发现的手段。
北美地区引领市场，2022 年收益占有率超过 58.0%。美国是人工智慧技术的先驱，为该地区的市场成长做出了重大贡献。

全球药物发现人工智慧 (AI) 市场：区域趋势分析
2021 年和 2030 年全球人工智慧 (AI) 在药物发现市场占有率（按地区）
北美洲
- 北美人工智慧
- 美国
- 加拿大
- 墨西哥
欧洲
- 欧洲人工智慧
- 英国
- 德国
- 法国
- 西班牙
- 义大利
- 丹麦
亚太地区
- 亚太人工智慧
- 中国
- 印度
- 日本
- 澳洲
- 韩国
拉丁美洲
- 拉丁美洲的人工智慧
- 巴西
- 阿根廷
中东/非洲
- 中东/非洲人工智慧
- 南非
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 科威特

第七章竞争分析

主要市场参与企业的最新趋势和影响分析
公司/竞争对手分类（主要创新者、市场领导、新兴企业）
竞争仪表板与公司市场分析
- 协同效应分析：重大交易与策略联盟
- 主要新兴企业/技术颠覆者/创新者名单

第八章竞争格局

IBM
- 公司简介
- 财务表现
- 供品
- 策略倡议
Exscientia
- 公司简介
- 财务表现
- 供品
- 策略倡议
GNS Healthcare（In January 2023, the company Rebranded as Aitia）
- 公司简介
- 财务表现
- 供品
- 策略倡议
Google（DeepMind）
- 公司简介
- 财务表现
- 供品
- 策略倡议
BenevolentAI
- 公司简介
- 财务表现
- 供品
- 策略倡议
BioSymetrics, Inc
- 公司简介
- 财务表现
- 供品
- 策略倡议
Atomwise Inc.
- 公司简介
- 财务表现
- 供品
- 策略倡议
Berg Health（In January 2023, BPGbio Inc. acquired Berg Health）
- 公司简介
- 财务表现
- 供品
- 策略倡议
insitro
- 公司简介
- 财务表现
- 供品
- 策略倡议
CYCLICA（In May 2023, CYCLICA acquired by Recursion）
- 公司简介
- 财务表现
- 供品
- 策略倡议

简介目录图表

Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Growth & Trends:

The global artificial intelligence in drug discovery market size was estimated at USD 9.1 billion in 2030, and is expected to expand at a CAGR of 29.7% from 2024 to 2030. It is expected to expand at a CAGR of 29.6% from 2023 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2022. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2022. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2022. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights:

The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 53.9% in 2022
By therapeutic area, the oncology segment held the largest revenue share of over 23.4% in 2022. The infectious diseases segment is expected to register the fastest growth rate during the forecast period
Asia Pacific is expected to expand at the fastest CAGR from 2023 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery
North America led the market and accounted for a revenue share of over 58.0% in 2022. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology

Chapter 1 Methodology and Scope

1.1 Research Methodology
- 1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources

Chapter 2 Executive Summary

2.1 Market Summary

Chapter 3 Global Artificial Intelligence (AI) in Drug Discovery Market Variables, Trends & Scope

3.1 Market Segmentation
3.2 Artificial Intelligence (AI) in Drug Discovery Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
- 3.2.4 Global Artificial Intelligence (AI) in Drug Discovery Market: Pestle Analysis
- 3.2.5 Global Artificial Intelligence (AI) in Drug Discovery Market: Porter's Analysis

Chapter 4 Global Artificial Intelligence (AI) in Drug Discovery Market: Application Estimates & Trend Analysis

4.1 Artificial Intelligence (AI) in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
- 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.3 Preclinical Testing
- 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Other Applications
- 4.4.1 Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Global Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

5.1 Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
- 5.2.1 Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3 Neurodegenerative Diseases
- 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Cardiovascular Disease
- 5.4.1 Cardiovascular Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Metabolic Diseases
- 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6 Infectious Disease
- 5.6.1 Infectious Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7 Others
- 5.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Global Artificial Intelligence (AI) in Drug Discovery Market: Regional Estimates & Trend Analysis

6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Movement Ananlysis, By region
6.2 Global Artificial Intelligence (AI) in Drug Discovery Market Share, By region, 2021 & 2030
6.3 North America
- 6.3.1 North America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.2 U.S.
  - 6.3.2.1 U.S. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.3 Canada
  - 6.3.3.1 Canada Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.4 Mexico
  - 6.3.4.1 Mexico Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Europe
- 6.4.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.2 U.K.
  - 6.4.2.1 U.K. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3 Germany
  - 6.4.3.1 Germany Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.4 France
  - 6.4.4.1 France Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.5 Spain
  - 6.4.5.1 Spain Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.6 Italy
  - 6.4.6.1 Italy Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.7 Denmark
  - 6.4.7.1 Denmark Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Asia Pacific
- 6.5.1 Asia Pacific Artificial intelligence (AI) in drug discovery market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.2 China
  - 6.5.2.1 China Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.3 India
  - 6.5.3.1 India Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.4 Japan
  - 6.5.4.1 Japan Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.5 Australia
  - 6.5.5.1 Australia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.6 South Korea
  - 6.5.6.1 South Korea Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Latin America
- 6.6.1 Latin America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.2 Brazil
  - 6.6.2.1 Brazil Artificial Intelligence (AI) in Drug Discovery Market
- 6.6.3 Argentina
  - 6.6.3.1 Argentina Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7 MEA
- 6.7.1 MEA Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.2 South Africa
  - 6.7.2.1 South Africa Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.3 Saudi Arabia
  - 6.7.3.1 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.4 UAE
  - 6.7.4.1 UAE Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.5 Kuwait
  - 6.7.5.1 Kuwait Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
- 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
- 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators

Chapter 8 Competitive Landscape

8.1 IBM
- 8.1.1 Company Overview
- 8.1.2 Finanacial Performance
- 8.1.3 Offerings
- 8.1.4 Strategic Initiatives
8.2 Exscientia
- 8.2.1 Company Overview
- 8.2.2 Finanacial Performance
- 8.2.3 Offerings
- 8.2.4 Strategic Initiatives
8.3 GNS Healthcare (In January 2023, the company Rebranded as Aitia)
- 8.3.1 Company Overview
- 8.3.2 Finanacial Performance
- 8.3.3 Offerings
- 8.3.4 Strategic Initiatives
8.4 Google (DeepMind)
- 8.4.1 Company Overview
- 8.4.2 Finanacial Performance
- 8.4.3 Offerings
- 8.4.4 Strategic Initiatives
8.5 BenevolentAI
- 8.5.1 Company Overview
- 8.5.2 Finanacial Performance
- 8.5.3 Offerings
- 8.5.4 Strategic Initiatives
8.6 BioSymetrics, Inc
- 8.6.1 Company Overview
- 8.6.2 Finanacial Performance
- 8.6.3 Offerings
- 8.6.4 Strategic Initiatives
8.7 Atomwise Inc.
- 8.7.1 Company Overview
- 8.7.2 Finanacial Performance
- 8.7.3 Offerings
- 8.7.4 Strategic Initiatives
8.8 Berg Health (In January 2023, BPGbio Inc. acquired Berg Health)
- 8.8.1 Company Overview
- 8.8.2 Finanacial Performance
- 8.8.3 Offerings
- 8.9.4 Strategic Initiatives
8.10 insitro
- 8.10.1 Company Overview
- 8.10.2 Finanacial Performance
- 8.10.3 Offerings
- 8.10.4 Strategic Initiatives
8.11 CYCLICA (In May 2023, CYCLICA acquired by Recursion)
- 8.11.1 Company Overview
- 8.11.2 Finanacial Performance
- 8.11.3 Offerings
- 8.11.4 Strategic Initiatives

简介目录图表

List of Tables

Table 1 Partial list of secondary sources
Table 2 North America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 3 North America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 U.S. Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 6 Canada Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 7 Canada Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 8 Mexico Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 9 Mexico Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 10 Europe Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 11 Europe Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 12 UK Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 13 UK Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 14 Germany Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 15 Germany Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 16 France Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 17 France Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 18 Spain Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 19 Spain Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 20 Italy Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 21 Italy Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 Denmark Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 23 Denmark Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 24 Sweden Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 25 Sweden Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Norway Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 27 Norway Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 China Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 31 China Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 32 India Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 33 India Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Japan Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 35 Japan Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 36 Australia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 37 Australia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 South Korea Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 39 South Korea Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 40 Latin America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 41 Latin America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Brazil Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 43 Brazil Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 44 Argentina Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 45 Argentina Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Middle East & Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 47 Middle East & Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 48 South Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 49 South Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Saudi Arabia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 51 Saudi Arabia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 52 UAE Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 53 UAE Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Kuwait Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 55 Kuwait Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Global Artificial Intelligence in drug discovery market snapshot, 2021 (USD Million)
Fig. 9 Global Artificial Intelligence in drug discovery market segmentation
Fig. 10 Global Artificial Intelligence in drug discovery market dynamics
Fig. 11 Global Artificial Intelligence in drug discovery market driver impact
Fig. 12 Global Artificial Intelligence in drug discovery market restraints impact
Fig. 13 Global Artificial Intelligence in drug discovery market - PESTLE analysis
Fig. 14 Global Artificial Intelligence in drug discovery market - Porter's Analysis
Fig. 15 Global Artificial Intelligence in drug discovery market - Application outlook and key takeaways
Fig. 16 Global Artificial Intelligence in drug discovery market - Application movement analysis
Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Preclinical testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Global Artificial Intelligence in drug discovery market - Therapeutic area outlook and key takeaways
Fig. 21 Global Artificial Intelligence in drug discovery market - Therapeutic area movement analysis
Fig. 22 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cardiovascular Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Metabolic Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Infectious Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Global Artificial Intelligence in drug discovery market - Regional outlook and key takeaways
Fig. 29 Global Artificial Intelligence in drug discovery market - Regional movement analysis
Fig. 30 North America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Mexico Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.K. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Spain Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Italy Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Denmark Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 India Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Latin America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Argentina Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Middle East & Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53. South Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 UAE Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Kuwait Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 58 Company market position analysis, 2023
Fig. 59 Strategic alliance and deals analysis